Literature DB >> 21442743

Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye.

Jiajia Chen1, Qianying Gao, Yaqin Liu, Jian Ge, Xianwu Cao, Yan Luo, Danping Huang, Gege Zhou, Shaofen Lin, Jianxian Lin, Chi Ho To, Andrew W Siu.   

Abstract

We previously proposed a new strategy to replace a vitreous body with a novel foldable capsular vitreous body (FCVB). In this study, the FCVB was designed to mimic natural vitreous morphology, and evaluate its physiological functions compared with traditional silicone oil substitutes, in an established rabbit model of proliferative vitreoretinopathy. We found that FCVB was a very good replacement for closely mimicking the morphology and restoring the physiological functions, such as the support, refraction, and cellular barriers, of the rabbit vitreous body. The study has provided us with a novel research and therapy strategy that could effectively mimic the morphology and physiological function of the rabbit vitreous body.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442743     DOI: 10.1002/jbm.b.31812

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  13 in total

1.  Vitreous substitutes: challenges and directions.

Authors:  Qian-Ying Gao; Yue Fu; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

2.  Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.

Authors:  Haihua Zheng; Zhimin Wang; Peijuan Wang; Yaqin Liu; Zhaoxin Jiang; Qianying Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-27       Impact factor: 3.117

3.  SILICONE OIL-FILLED FOLDABLE CAPSULAR VITREOUS BODY VERSUS SILICONE OIL ENDOTAMPONADE FOR TREATMENT OF NO LIGHT PERCEPTION AFTER SEVERE OCULAR TRAUMA.

Authors:  Chun Zhang; Ruihan Xiao; Anan Wang; Zhenquan Zhao
Journal:  Retina       Date:  2022-03-01       Impact factor: 3.975

4.  The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.

Authors:  Qianying Gao; Wencong Wang; Yuqing Lan; Xiaoqing Chen; Wei Yang; Yongguang Yuan; Juan Tan; Yao Zong; Zhaoxin Jiang
Journal:  Int J Nanomedicine       Date:  2013-04-19

5.  Protein kinase Cα downregulation via siRNA-PKCα released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells.

Authors:  Xiaoqing Chen; Yaqin Liu; Zhaoxin Jiang; Lian Zhou; Jian Ge; Qianying Gao
Journal:  Int J Nanomedicine       Date:  2011-06-22

6.  Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice.

Authors:  Juan Tan; Yaqin Liu; Wei Li; Qianying Gao
Journal:  Mol Vis       Date:  2012-04-07       Impact factor: 2.367

7.  Preliminary study on retinal vascular and oxygen-related changes after long-term silicone oil and foldable capsular vitreous body tamponade.

Authors:  Wei Yang; Yongguang Yuan; Yao Zong; Zhen Huang; Shuyi Mai; Yujie Li; Xiaobing Qian; Yaqin Liu; Qianying Gao
Journal:  Sci Rep       Date:  2014-06-12       Impact factor: 4.379

8.  Study on the effectiveness and safety of Foldable Capsular Vitreous Body implantation.

Authors:  Xiangyang Zhang; Xuemin Tian; Baike Zhang; Lisa Guo; Xiaodan Li; Yong Jia
Journal:  BMC Ophthalmol       Date:  2019-12-18       Impact factor: 2.209

9.  Comprehensive analysis of inflammatory immune mediators of the intraocular fluid aspirated from the foldable capsular vitreous body filled-eyes.

Authors:  Peijuan Wang; Qianying Gao; Xiaofeng Lin; Shaochong Zhang; Jie Hu; Yaqin Liu; Nuo Xu; Jian Ge
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.

Authors:  Songfu Feng; Han Chen; Yaqin Liu; Zhen Huang; Xuyuan Sun; Lian Zhou; Xiaohe Lu; Qianying Gao
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.